Acute Myeloid Leukemia Patients Inform Adoptive Cell Therapy

A limitation to cancer treatment, specifically acute myeloid leukemia (AML) is the ability to effectively target tumors cells without harming healthy tissue or blood cells. This is a side effect of most therapies since cells all share similar markers and…

Continue Reading

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *